Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,003,246 papers from all fields of science
Search
Sign In
Create Free Account
FDA Approval
A written regulatory communication from FDA to an applicant, who submitted request to the agency to approve marketing or to license medical product…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
5-ALA and FDA approval for glioma surgery
C. Hadjipanayis
,
W. Stummer
Journal of Neuro-Oncology
2019
Corpus ID: 58006836
The US Food and Drug Administration (FDA) approved 5-aminolevulinic acid (5-ALA; Gleolan®; photonamic GmbH and Co. KG) for use as…
Expand
2018
2018
Flexible FDA Approval Policies 1
2018
Corpus ID: 264733040
Since its establishment in 1906, the U.S. Food and Drug Administration (FDA) has approved over 1,500 novel drugs, with total…
Expand
2017
2017
The Long and Winding Road After FDA Approval: A Medical Device Industry Perspective.
K. Stein
Circulation
2017
Corpus ID: 207708161
> The road is long > > With many a winding turn > > That leads us to who knows where > > Who knows where > > —“He Ain’t…
Expand
Highly Cited
2017
Highly Cited
2017
FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug.
P. Bach
,
S. Giralt
,
L. Saltz
Journal of the American Medical Association (JAMA…
2017
Corpus ID: 205086914
Approval of the drugtisagenlecleucel(Kymriah;Novartis) by the US Food and Drug Administration (FDA) for the treatment of…
Expand
Review
2015
Review
2015
PRECICE intramedullary limb lengthening system
D. Paley
Expert Review of Medical Devices
2015
Corpus ID: 207201352
The PRECICE® Intramedullary Limb Lengthening System (Ellipse Technologies Inc., CA, USA) is a remotely controlled, magnetically…
Expand
2013
2013
A Generic Problem: Should FDA Approval of Drugs Stop Consumers’ Suits for Injuries?
Jd Larry Bumgardner
2013
Corpus ID: 186442688
Highly Cited
2010
Highly Cited
2010
The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?
Olivier Wellman‐Labadie
,
Youwen Zhou
Health Policy
2010
Corpus ID: 29346890
2004
2004
[FDA approval for the antidepressive drug Cymbalta].
Krankenpflege Journal
2004
Corpus ID: 40253900
Review
2004
Review
2004
Enzyme replacement therapy for Fabry disease: lessons from two α-galactosidase A orphan products and one FDA approval
R. Desnick
Expert Opinion on Biological Therapy
2004
Corpus ID: 26541619
Two virtually identical products have been developed for enzyme replacement therapy for the treatment of Fabry disease, which is…
Expand
Review
2000
Review
2000
Progress in antisense technology: the end of the beginning.
S. Crooke
Methods in Enzymology
2000
Corpus ID: 30680447
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE